Generic Small Molecules
Total Trials
20
As Lead Sponsor
As Collaborator
0
Total Enrollment
1,622
NCT00635505
Controlled, 12-Week Study of Albuterol HFA Versus the Active Control, Proventil(R)-HFA in Asthmatic Patients
Phase: Phase 3
Role: Lead Sponsor
Start: Sep 30, 2007
Completion: Aug 31, 2008
NCT00634829
Single-Dose Cross-Over Study of the Effects of Albuterol-HFA in Exercise Induced Bronchoconstriction
Start: Feb 29, 2008
Completion: Oct 31, 2008
NCT00634517
4-Week Study of Efficacy, Safety and PK of Albuterol-HFA Versus Proventil-HFA in Pediatric Asthma
Start: Mar 31, 2008
Completion: Dec 31, 2008
NCT01025648
Randomized, Placebo/Active Crossover Dose-ranging Study for Safety and Efficacy in Asthma Patients.
Phase: Phase 1/2
Start: Dec 31, 2009
Completion: Dec 31, 2009
NCT01143051
Pharmacokinetics (PK) Study of Epinephrine Inhalation Aerosol in Healthy Volunteers
Start: Jan 31, 2010
Completion: Jun 30, 2010
NCT01174732
Dose-Ranging Study of A006 DPI, in Adult Asthma Patients
Phase: Phase 2
Start: Jul 31, 2010
Completion: Jan 31, 2011
NCT01189396
Escalating and Cumulative-Dose Study of Pharmacokinetics (PK), Pharmacodynamics (PD) and Safety of A006
NCT01188577
Epinephrine Inhalation Aerosol USP, a HFA-MDI Study for Assessment of Pharmacokinetics
Start: Aug 31, 2010
NCT01255709
Epinephrine Inhalation Aerosol USP, CLINICAL STUDY-B3 FOR ASSESSMENT OF PHARMACOKINETICS
Start: Dec 31, 2010
NCT01357642
Epinephrine Inhalation Aerosol USP: For Evaluation Of Efficacy And Safety In Asthma Patients
Start: Jul 31, 2011
Completion: Dec 31, 2011
NCT01460511
Evaluation of Efficacy and Safety of E004 in Children With Asthma
Start: Oct 31, 2011
Completion: Jul 31, 2012
NCT01476904
Safety Study in Adolescent and Adult Patients With Asthma
Start: Nov 30, 2011
NCT01581177
Albuterol DPI (A006) Clinical Study-B2: Efficacy, Dose-Ranging and Initial Safety Evaluation
Start: Apr 30, 2012
Completion: Aug 31, 2012
NCT01689363
Evaluation of the Allergenicity of AMPHADASE INJECTION (Hyaluronidase Injection USP)
Start: Sep 30, 2012
Completion: Dec 31, 2012
NCT01737905
Evaluation of Efficacy and Safety for Single Dose of E004 in Children With Asthma
Start: Oct 31, 2012
Completion: Dec 31, 2013
NCT01737892
Assessment and Evaluation of Pharmacokinetic Profile of E004 in Healthy Adults
Start: Nov 30, 2012
Completion: Nov 30, 2012
NCT02210806
Albuterol DPI (A006) Clinical Study-B3:Efficacy, Dose-ranging and Safety Evaluation
Start: Jul 31, 2014
Completion: Oct 31, 2014
NCT02271334
Evaluation of Pharmacokinetics and Safety of A006 in Healthy Volunteers
Start: Aug 31, 2014
Completion: Mar 31, 2015
NCT04207840
Study of Drug Exposure in Systemic Circulation of Primatene Mist by Oral Inhalation, Versus Epinephrine Injection by Intramuscular Injection and ProAir by Oral Inhalation in Healthy Individuals
Phase: Phase 4
Start: Dec 9, 2019
Completion: Dec 23, 2019
NCT05539872
Comparison of the Pharmacokinetics (PK) and Pharmacodynamics (PD) Biosimilarity of Proposed Biosimilar Rapid-Acting Insulin Aspart (I004) and NovoLog After Single-Dose Subcutaneous Administration to Healthy Volunteers
Phase: Phase 2/3
Start: Aug 22, 2022
Completion: Jan 30, 2023
Loading map...